← Leaderboards
Doron Betel
Sloan-Kettering Inst Can Research
$3,410,013
Attributed
$6,820,025
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,820,025 · 2
By mechanism
R01$6,820,025 · 2
Top collaborators
- Lorenz P. Studer11 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Lorenz P. Studer$24,153,805
- Ping Chi$18,562,542
- Sujata Patil$291,181
Others in their field
Other Emerging Leaders on “Induced Pluripotent Stem Cell”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Deborah Requesens · Coriell Institute For Medical Research$12,073,825
- Nicholas Andrew Geisse · Curi Bio Inc$10,751,683
- Yin Shen · University Of California, San Francisco$10,582,142
- Jessica Elaine Young · University Of Washington$8,375,810
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$8,312,550
Research focus
Induced Pluripotent Stem CellEmbryoTechnologyBrainGeneticIn VitroDisease ModelPathway InteractionsPhenotypeInsightParkinson DiseaseHuman DiseaseCellsNeuronsCell TypeCell LineDrug DiscoveryMolecularDopaminergic NeuronDopamineMidbrain StructureChromatinIn VivoProtocols Documentation
Grant awards (11)
Novel strategies for induction of aging in human PSC-derived lineages for modeling Alzheimer's Disease$859,466
R01 · FY2025 · AG
Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons$635,925
R01 · FY2025 · NS
Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons$617,673
R01 · FY2024 · NS
Directing Fate, Subtype Identity and Survival in Human Pluripotent-Derived Midbrain Dopamine Neurons$636,922
R01 · FY2023 · NS
Directing fate, subtype identity and survival in human pluripotent-derived midbrain dopamine neurons$637,063
R01 · FY2022 · NS
Directing fate, subtype identity and survival in human pluripotent-derived midbrain dopamine neurons$675,698
R01 · FY2021 · NS
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases$505,452
R01 · FY2021 · AG
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases$568,510
R01 · FY2020 · AG
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases$568,510
R01 · FY2019 · AG
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases$552,795
R01 · FY2018 · AG
Novel strategies for induction of aging in human iPSC-derived lineages towards improved models of late-onset diseases$562,011
R01 · FY2017 · AG